Sichuan Hebang Biotechnology Hits Day Low at CNY 2.77 Amid Price Pressure

Sichuan Hebang Biotechnology Co., Ltd. experienced significant volatility on March 20, 2026, with the stock declining by 10.06% and reaching an intraday low of CNY 2.77. This performance starkly contrasts with the China Shanghai Composite, which fell by only 1.24% on the same day. Over the past week, Sichuan Hebang's stock has decreased by 8.58%, while its one-month performance shows a notable increase of 16.39%. However, the year-to-date performance remains positive at 22.57%, and the stock has appreciated by 48.13% over the past year. Despite these gains, the company has faced challenges, including a decline in net profit and negative results for the last ten consecutive quarters. Financial metrics indicate that the company has a market capitalization of CNY 21,018 million and a debt-to-equity ratio of 0.11. The return on equity stands at -1.02%, reflecting ongoing financial pressures. Investors may want to consider these factors as they assess the company's current market position within the Chemicals & Petrochemicals industry.